Loading...
Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells
Bone destruction induced by the metastasis of breast cancer cells is a frequent complication that is caused by the interaction between cancer cells and bone cells. Receptor activator of nuclear factor kappa-B ligand (RANKL) and the endogenous soluble RANKL inhibitor, osteoprotegerin (OPG), directly...
Na minha lista:
| Udgivet i: | J Cancer Prev |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Korean Society of Cancer Prevention
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4699756/ https://ncbi.nlm.nih.gov/pubmed/26734591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15430/JCP.2015.20.4.281 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|